©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessMukopolysaccharidosen, Differentialdiagnose II

Summary

Short information

Comprehensive differential diagnostic panel for Mucopolysaccharidoses comprising 20 curated genes according to the clinical signs

ID
MP0401
Number of loci
Loci typeCount
Gen22
Accredited laboratory test
Examined sequence length
23,2 kb (Core-/Core-canditate-Genes)
45,9 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

 

Loci panel

Gen

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
ARSB1602NM_000046.5AR
GALNS1569NM_000512.5AR
GLB12034NM_000404.4AR
GNPTAB3771NM_024312.5AR
GNS1659NM_002076.4AR
GUSB1956NM_000181.4AR
HGSNAT1908NM_152419.3AR
HYAL11308NM_153281.2AR
IDS1653NM_000202.8XLR
IDUA1962NM_000203.5AR
NAGLU2232NM_000263.4AR
SGSH1509NM_000199.5AR
COL2A14464NM_001844.5AD
GLA1290NM_000169.3XL
GNPTG918NM_032520.5AR
MAN2B13036NM_000528.4AR
NEU11248NM_000434.4AR
PSAP1575NM_002778.4AR
RAI15721NM_030665.4AD
SMARCAL12865NM_001127207.2AR
SUMF11125NM_182760.4AR
TRAPPC2423NM_001011658.4XLR

Informations about the disease

Clinical Comment

illness_ClinicalComment_MP0401

 

Synonyms
  • Allelic: Charcot-Marie-Tooth disease, axonal, type 2V (NAGLU)
  • Allelic: Lewy body dementia, susceptibility to (GBA)
  • Allelic: Parkinson disease 24, AD, susceptibility to (PSAP)
  • Allelic: Parkinson disease, late-onset, susceptibility to (GBA)
  • Allelic: Retinitis pigmentosa 73 (HGSNAT)
  • Combined SAP deficiency (PSAP)
  • Fabry disease (GLA)
  • Fabry disease, cardiac variant (GLA)
  • GM1-gangliosidosis type I-III (GLB1)
  • Gaucher disease, atypical (PSAP)
  • Gaucher disease, perinatal lethal (GBA)
  • Gaucher disease, type I, II, III, IIIC (GBA)
  • Krabbe disease, atypical (PSAP)
  • Mannosidosis, alpha-, types I + II (MAN2B1)
  • Metachromatic leukodystrophy due to SAP-b deficiency (PSAP)
  • Mucolipidosis II alpha/beta (GNPTAB)
  • Mucolipidosis III alpha/beta (GNPTAB)
  • Mucolipidosis IV (MCOLN1)
  • Mucopolysaccharidosis type II, Hunter syndrome (IDS)
  • Mucopolysaccharidosis type IIIA, Sanfilippo A (SGSH)
  • Mucopolysaccharidosis type IIIB, Sanfilippo B (NAGLU)
  • Mucopolysaccharidosis type IIIC, Sanfilippo C (HGSNAT)
  • Mucopolysaccharidosis type IIID, Sanfilippo syndrome D (GNS)
  • Mucopolysaccharidosis type IVA (GALNS)
  • Mucopolysaccharidosis type IVB, Morquio (GLB1)
  • Mucopolysaccharidosis type IX (HYAL1)
  • Mucopolysaccharidosis type Ih/s, Hurler-Scheie syndrome+ Is, Scheie syndrome (IDUA)
  • Mucopolysaccharidosis type VI, Maroteaux-Lamy (ARSB)
  • Mucopolysaccharidosis type VII, Sly syndrome (GUSB)
  • Mucopolysaccharidosis type X (ARSK)
  • Mucopolysaccharidosis-plus syndrome (VPS33A)
  • Multiple sulfatase deficiency (SUMF1)
  • Osteoarthritis with mild chondrodysplasia (COL2A1)
  • Schimke immunoosseous dysplasia (SMARCAL1)
  • Sialidosis, type I (NEU1)
  • Sialidosis, type II (NEU1)
  • Smith-Magenis syndrome (RAI1)
  • Spondyloepiphyseal dysplasia tarda (TRAPPC2)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XL
  • XLR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined